Antibody response against nucleocapsid and spike proteins of SARS-CoV-2 in 11 persons with mild or asymptomatic infection rapidly increased after infection. At weeks 18-30 after diagnosis, all remained seropositive but spike protein-targeting antibody titers declined. These data may be useful for vaccine development
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...
More than a year after the start of the pandemic, COVID-19 remains a global health emergency. Althou...
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
Anti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we characteriz...
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented stra...
Understanding persistent cellular and humoral immune responses to SARS-CoV-2 will be of major import...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Purpose Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the ...
International audienceAbstract The comprehension of a long-term humoral immune response against SARS...
Purpose Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the ...
Most of the individuals infected with SARS coronavirus (SARS-CoV) spontaneously recovered without cl...
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...
More than a year after the start of the pandemic, COVID-19 remains a global health emergency. Althou...
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
Anti-viral immunity continuously declines over time after SARS-CoV-2 infection. Here, we characteriz...
SARS-CoV-2 pandemic is causing high morbidity and mortality burden worldwide with unprecedented stra...
Understanding persistent cellular and humoral immune responses to SARS-CoV-2 will be of major import...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Background: Emerging data support detectable immune responses for months after severe acute respirat...
Purpose Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the ...
International audienceAbstract The comprehension of a long-term humoral immune response against SARS...
Purpose Antibody assays against SARS-CoV-2 are used in sero-epidemiological studies to estimate the ...
Most of the individuals infected with SARS coronavirus (SARS-CoV) spontaneously recovered without cl...
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...
More than a year after the start of the pandemic, COVID-19 remains a global health emergency. Althou...
Background Neutralizing antibodies are important for protection against the pandemic SARS-CoV-2 viru...